[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]

Ned Tijdschr Geneeskd. 1999 Nov 20;143(47):2383-5.
[Article in Dutch]


The role of reinfection and the importance of partner treatment were added to a pharmacoeconomic model for the analysis of a GP-based opportunistic screening programme for Chlamydia trachomatis (CT) in sexually active women in Amsterdam. A favourable cost-effectiveness was found for partner treatment. Partner treatment was cost saving and overall net costs per major outcome averted by the screening programme were reduced by 40% or more due to partner treatment. From a pharmacoeconomic point of view partner treatment should be routinely provided in the framework of a CT screening programme for Amsterdam women.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / economics*
  • Anti-Bacterial Agents / therapeutic use
  • Chlamydia Infections / drug therapy
  • Chlamydia Infections / economics*
  • Chlamydia Infections / epidemiology
  • Chlamydia Infections / prevention & control*
  • Chlamydia trachomatis*
  • Cohort Studies
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Male
  • Mass Screening / economics*
  • Mass Screening / methods
  • Netherlands / epidemiology
  • Population Surveillance*
  • Secondary Prevention
  • Sexual Partners*


  • Anti-Bacterial Agents